Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis mdm2'

Search results for: 'research area apoptosis mdm2'

Items 21-29 of 29

Page
per page
  1. DMXAA (Vadimezan)
    A8233 DMXAA (Vadimezan)
     2 Citation
    Target: DT-diaphorases
    Summary: Tumnor vascular disrupting agent, apoptosis inducer
      insoluble in H2O; insoluble in EtOH; ≥14.1 mg/mL
  2. GKT137831
    B4763 GKT137831
     1 Citation
    Target: NADPH Oxidases
    Summary: dual NADPH oxidase Nox1/Nox4 inhibitor
      ≥39.5 mg/mL
  3. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  4. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  5. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL
  6. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  7. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  8. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL
  9. PCI-34051
    A4091 PCI-34051
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC8 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL

Items 21-29 of 29

Page
per page